V

VolitionRX Limited
D

VNRX

0.73080
USD
-0.01
(-1.24%)
مغلق
حجم التداول
902
الربح لكل سهم
-0
العائد الربحي
-
P/E
-3
حجم السوق
75,990,060
أصول ذات صلة
AAPL
AAPL
0.060
(0.03%)
214.010 USD
AMZN
AMZN
1.360
(0.59%)
232.810 USD
GOOGL
GOOGL
-0.620
(-0.32%)
192.550 USD
MSFT
MSFT
-1.34
(-0.26%)
512.40 USD
NFLX
NFLX
-5.78
(-0.49%)
1,174.94 USD
NVDA
NVDA
3.280
(1.89%)
176.780 USD
PYPL
PYPL
0.275
(0.35%)
78.270 USD
TSLA
TSLA
9.43
(2.98%)
325.54 USD
V
V
-1.56
(-0.44%)
355.53 USD
المزيد
الأخبار المقالات

العنوان: VolitionRX Limited

القطاع: Healthcare
الصناعة: Medical Devices
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.